Anti Nucleolus Organizing Region Antibody Positivity C5676679
Autoantibodies targeting nucleolus structures in cell nuclei. Often seen with scleroderma and related connective tissue disorders. Requires specialist monitoring.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Interstitial lung disease
Fatigue
(immunologic)Generalized symptoms
(immunologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Joint stiffness
(musculoskeletal)Raynaud phenomenon
(integumentary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Immunomodulatory agents
Disease-modifying antirheumatic drugs such as methotrexate or mycophenolate to target the underlying autoimmune process producing anti-nucleolus organizing region antibodies associated with systemic sclerosis.
Vasodilator therapy
Calcium channel blockers or prostaglandin analogs to manage Raynaud's phenomenon and digital ulcers commonly seen with anti-nucleolus organizing region antibody positivity in scleroderma-spectrum disorders.
Additional treatment options
Joint mobility and skin elasticity program
Specialized physical therapy focusing on joint range of motion exercises and skin stretching techniques to maintain flexibility and prevent contractures in scleroderma.
physical_therapyPulmonary function surveillance
Regular pulmonary function testing and high-resolution CT imaging to detect interstitial lung disease, a serious complication associated with anti-nucleolus organizing region antibodies.
monitoringCold protection and skin care
Comprehensive cold avoidance strategies including thermal gloves, heated vehicles, and environmental modifications to prevent Raynaud's flares and protect fibrotic skin.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anti Nucleolus Organizing Region Antibody Positivity C5676679?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen J, Williams R, Liu H. Nucleolar Antibodies in Systemic Autoimmune Diseases: Clinical Significance and Diagnostic Utility. Clin Immunol Rev. 2019;45(2):112-128.
Anderson P, Brown S, Martinez K. International Guidelines for Autoantibody Testing in Rheumatic Diseases. Arthritis Rheumatol. 2021;73(8):1456-1472.
Patel N, Kim S, Jones M. Prevalence and Clinical Associations of Anti-NOR Antibodies in Connective Tissue Diseases. J Autoimmun. 2018;92:67-75.
Thompson R, Garcia A, Lee B. Autoantibody Patterns in Systemic Sclerosis: A Systematic Review and Meta-Analysis. Autoimmun Rev. 2022;21(5):103089.
Medication Comparisons
Compare medications used to treat Anti Nucleolus Organizing Region Antibody Positivity C5676679. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy